Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16812)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 26, 2019 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hanson E, Sheldon M, Pacheco B, Alkubeysi M, Raizada V. Heart disease in Friedreich’s ataxia. World J Cardiol 2019; 11(1): 1-12 [PMID: 30705738 DOI: 10.4330/wjc.v11.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v11/i1/1.htm |
| Number | Citing Articles |
| 1 |
Antonis S. Manolis, Antonis A. Manolis, Theodora A. Manolis, Naomi E. Apostolaki, Evdoxia J. Apostolopoulos, Helen Melita, Niki Katsiki. Mitochondrial dysfunction in cardiovascular disease: Current status of translational research/clinical and therapeutic implications. Medicinal Research Reviews 2021; 41(1): 275 doi: 10.1002/med.21732
|
| 2 |
Yutong Liu, Jing Cai, Jiaqi Shen, Weichen Dong, Li Xu, Maoxin Fang, Yishan Lin, Jiali Liu, Yibing Ding, Tong Qiao, Kuanyu Li. SS-31 efficacy in a mouse model of Friedreich ataxia by upregulation of frataxin expression. Human Molecular Genetics 2021; 31(2): 176 doi: 10.1093/hmg/ddab232
|
| 3 |
Mariana B. Angulo, Alexander Bertalovitz, Mariana A. Argenziano, Jiajia Yang, Aarti Patel, Theresa Zesiewicz, Thomas V. McDonald. Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC‐neurons and cardiomyocytes. Molecular Genetics & Genomic Medicine 2023; 11(1) doi: 10.1002/mgg3.2093
|
| 4 |
Márta Janáky, Gábor Braunitzer. Syndromic Retinitis Pigmentosa: A Narrative Review. Vision 2025; 9(1): 7 doi: 10.3390/vision9010007
|
| 5 |
S. Chiang, M.L.H. Huang, D.R. Richardson. Treatment of dilated cardiomyopathy in a mouse model of Friedreich’s ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis. Pharmacological Research 2020; 159: 104994 doi: 10.1016/j.phrs.2020.104994
|
| 6 |
Reza Heidari, Mohammad Mehdi Ommati, Hossein Niknahad. Mitochondrial Metabolism. 2021; : 19 doi: 10.1016/B978-0-12-822416-8.00008-7
|
| 7 |
R. Mark Payne. Cardiovascular Research in Friedreich Ataxia. JACC: Basic to Translational Science 2022; 7(12): 1267 doi: 10.1016/j.jacbts.2022.04.005
|
| 8 |
Sharan R. Srinivasan, Claudio Melo de Gusmao, Joanna A. Korecka, Vikram Khurana. Neurobiology of Brain Disorders. 2023; : 293 doi: 10.1016/B978-0-323-85654-6.00048-4
|
| 9 |
Miranda K. Culley, Jingsi Zhao, Yi Yin Tai, Ying Tang, Dror Perk, Vinny Negi, Qiujun Yu, Chen-Shan C. Woodcock, Adam Handen, Gil Speyer, Seungchan Kim, Yen-Chun Lai, Taijyu Satoh, Annie M.M. Watson, Yassmin Al Aaraj, John Sembrat, Mauricio Rojas, Dmitry Goncharov, Elena A. Goncharova, Omar F. Khan, Daniel G. Anderson, James E. Dahlman, Aditi U. Gurkar, Robert Lafyatis, Ahmed U. Fayyaz, Margaret M. Redfield, Mark T. Gladwin, Marlene Rabinovitch, Mingxia Gu, Thomas Bertero, Stephen Y. Chan. Frataxin deficiency promotes endothelial senescence in pulmonary hypertension. Journal of Clinical Investigation 2021; 131(11) doi: 10.1172/JCI136459
|
| 10 |
Keira J.A. Johnston, Alanna C. Cote, Emily Hicks, Jessica Johnson, Laura M. Huckins. Genetically Regulated Gene Expression in the Brain Associated With Chronic Pain: Relationships With Clinical Traits and Potential for Drug Repurposing. Biological Psychiatry 2024; 95(8): 745 doi: 10.1016/j.biopsych.2023.08.023
|
| 11 |
Massimo Pandolfo. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. 2025; : 107 doi: 10.1016/B978-0-443-19176-3.00041-8
|
| 12 |
Andrea Quatrana, Elena Morini, Francesca Tiano, Chiara Vancheri, Luca Panarello, Silvia Romano, Christian Marcotulli, Carlo Casali, Caterina Mariotti, Alessia Mongelli, Mario Fichera, Alessandra Rufini, Ivano Condò, Giuseppe Novelli, Roberto Testi, Francesca Amati, Florence Malisan. Hsa-miR223-3p circulating level is upregulated in Friedreich’s ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1. Human Molecular Genetics 2022; 31(12): 2010 doi: 10.1093/hmg/ddac005
|
| 13 |
Wing-Hang Tong, Hayden Ollivierre, Audrey Noguchi, Manik C. Ghosh, Danielle A. Springer, Tracey A. Rouault. Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia. Heliyon 2022; 8(8): e10371 doi: 10.1016/j.heliyon.2022.e10371
|
| 14 |
Michele Russo, Annachiara Nuzzo, Matteo Foschi, Simona Boarin, Stefano Lorenzetti, Corrado Tomasi, Pietro Querzani, Andrea Rubboli. Left atrial appendage thrombosis in a patient with Friedreich Ataxia–related cardiomyopathy, left ventricular systolic dysfunction, and atrial fibrillation. SAGE Open Medical Case Reports 2021; 9 doi: 10.1177/2050313X211056419
|
| 15 |
Yu. A. Lutokhina, O. V. Blagova, E. A. Kogan, A. A. Nartov, V. R. Nartova, E. V. Zaklyazminskaya, S. L. Dzemeshkevich. Prevalence of myocarditis and its contribution to the course of primary myocardial hypertrophy. Russian Journal of Cardiology 2023; 28(11): 5528 doi: 10.15829/1560-4071-2023-5528
|
| 16 |
Saba Naghipour, Louise A. Corben, Amy J. Hulme, Mirella Dottori, Martin B. Delatycki, Jarmon G. Lees, Shiang Y. Lim. Omaveloxolone for the Treatment of Friedreich Ataxia: Efficacy, Safety, and Future Perspectives. Movement Disorders 2024; doi: 10.1002/mds.30070
|
| 17 |
Wing-Hang Tong, Hayden Ollivierre, Audrey Noguchi, Manik Ghosh, Danielle A. Springer, Tracey A. Rouault. Hyperactivation of mTORC1 in a Cardiac Hypertrophy Animal Model of Friedreich's Ataxia. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3963599
|
| 18 |
Teerapat Rojsajjakul, Nithya Selvan, Bishnu De, Jonathan B. Rosenberg, Stephen M. Kaminsky, Dolan Sondhi, Peter Janki, Ronald G. Crystal, Clementina Mesaros, Richie Khanna, Ian A. Blair. Expression and processing of mature human frataxin after gene therapy in mice. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59060-0
|
| 19 |
Sandra Mastroianno, Michele Germano, Angela Maggio, Raimondo Massaro, Domenico Rosario Potenza, Aldo Russo, Massimo Carella, Giuseppe Di Stolfo. Electrocardiogram in Friedreich's ataxia: A short‐term surrogate endpoint for treatment efficacy. Annals of Noninvasive Electrocardiology 2021; 26(4) doi: 10.1111/anec.12813
|
| 20 |
Poornima Jayadev Menon, Tan Xin Yi, Sharon Moran, Richard A. Walsh, Sinéad M. Murphy, Petya Bogdanova-Mihaylova. Health-Related Quality of Life in Patients with Inherited Ataxia in Ireland. The Cerebellum 2023; 23(4): 1328 doi: 10.1007/s12311-023-01640-3
|
| 21 |
Medina Keita, Kellie McIntyre, Layne N Rodden, Kim Schadt, David R Lynch. Friedreich Ataxia: Clinical Features and New Developments. Neurodegenerative Disease Management 2022; 12(5): 267 doi: 10.2217/nmt-2022-0011
|
| 22 |
Megan M. Shen, Christian Rummey, David R. Lynch. Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort. Annals of Clinical and Translational Neurology 2024; 11(5): 1110 doi: 10.1002/acn3.52027
|
| 23 |
Marie Beaudin, Mario Manto, Jeremy D. Schmahmann, Massimo Pandolfo, Nicolas Dupre. Recessive cerebellar and afferent ataxias — clinical challenges and future directions. Nature Reviews Neurology 2022; 18(5): 257 doi: 10.1038/s41582-022-00634-9
|
| 24 |
Sze Yuen Lew, Nur Shahirah Mohd Hisam, Michael Weng Lok Phang, Syarifah Nur Syed Abdul Rahman, Rozaida Yuen Ying Poh, Siew Huah Lim, Mohd Amir Kamaruzzaman, Sze Chun Chau, Ka Chun Tsui, Lee Wei Lim, Kah Hui Wong. Adenosine Improves Mitochondrial Function and Biogenesis in Friedreich’s Ataxia Fibroblasts Following L-Buthionine Sulfoximine-Induced Oxidative Stress. Biology 2023; 12(4): 559 doi: 10.3390/biology12040559
|
| 25 |
Priyanka Gera, Vitor De Oliveira, William H. Frishman, Wilbert S. Aronow. Cardiac Manifestations of Hemochromatosis. Cardiology in Review 2024; doi: 10.1097/CRD.0000000000000762
|
| 26 |
Bojjibabu Chidipi, Mariana Burgos Angulo, Syed Islamuddin Shah, Michelle Rieser, Ganim Ullah, Thomas V. McDonald, Sami F. Noujaim. The dynamin-related protein 1 is decreased and the mitochondrial network is altered in Friedreich’s ataxia cardiomyopathy. The International Journal of Biochemistry & Cell Biology 2022; 143: 106137 doi: 10.1016/j.biocel.2021.106137
|
| 27 |
Cheick A. K. Cissé, Lassana Cissé, Hamidou O. Ba, Oumar Samassékou, Assiatou Simaga, Abdoulaye Taméga, Salimata Diarra, Seybou H. Diallo, Thomas Coulibaly, Salimata Diallo, Abdoulaye Yalcouyé, Alassane B. Maiga, Mohamed Keita, Kenneth H. Fischbeck, Sékou F. Traoré, Cheick O. Guinto, Guida Landouré. Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family. Clinical Case Reports 2021; 9(5) doi: 10.1002/ccr3.4065
|
| 28 |
Erika Mejia, Abigail Lynch, Patrick Hearle, Oluwatimilehin Okunowo, Heather Griffis, Maully Shah, David Lynch, Kimberly Y. Lin. Ectopic Burden via Holter Monitors in Friedreich Ataxia. Pediatric Neurology 2021; 117: 29 doi: 10.1016/j.pediatrneurol.2021.01.004
|
| 29 |
Pei-Yu Chen, Lingfeng Qin, Michael Simons. TGFβ signaling pathways in human health and disease. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1113061
|
| 30 |
Miloš Kubánek. New approaches in the diagnosis of hypertrophic cardiomyopathy. Vnitřní lékařství 2024; 70(6): 376 doi: 10.36290/vnl.2024.075
|
| 31 |
Jarmon G. Lees, Marek Napierala, Alice Pébay, Mirella Dottori, Shiang Y. Lim. Cellular pathophysiology of Friedreich's ataxia cardiomyopathy. International Journal of Cardiology 2022; 346: 71 doi: 10.1016/j.ijcard.2021.11.033
|
| 32 |
Bianca Seminotti, Mateus Grings, Paolo Tucci, Guilhian Leipnitz, Luciano Saso. Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders. Frontiers in Cellular Neuroscience 2021; 15 doi: 10.3389/fncel.2021.785057
|
| 33 |
Faith A. A. Kwa, Evie Kendal. Precision medicine and Friedreich ataxia: promoting equity, beneficence, and informed consent for novel gene therapies. International Journal for Equity in Health 2024; 23(1) doi: 10.1186/s12939-024-02318-w
|
| 34 |
Joanna Poole, David Ray. The Role of Circadian Clock Genes in Critical Illness: The Potential Role of Translational Clock Gene Therapies for Targeting Inflammation, Mitochondrial Function, and Muscle Mass in Intensive Care. Journal of Biological Rhythms 2022; 37(4): 385 doi: 10.1177/07487304221092727
|
| 35 |
Carlos Munoz-Zuluaga, Monica Gertz, Melissa Yost-Bido, Alessandria Greco, Nicholas Gorman, Alvin Chen, Vikrum Kooner, Jonathan B. Rosenberg, Bishnu P. De, Stephen M. Kaminsky, Alain Borczuk, Rodolfo J. Ricart Arbona, Heather R. Martin, Sebastien Monette, Richie Khanna, Jay A. Barth, Ronald G. Crystal, Dolan Sondhi. Identification of Safe and Effective Intravenous Dose of AAVrh.10hFXN to Treat the Cardiac Manifestations of Friedreich's Ataxia. Human Gene Therapy 2023; 34(13-14): 605 doi: 10.1089/hum.2023.020
|
| 36 |
Christiana O. Salami, Katie Jackson, Clarisse Jose, Laith Alyass, Georges-Ibrahim Cisse, Bishnu P. De, Katie M. Stiles, Maria J. Chiuchiolo, Dolan Sondhi, Ronald G. Crystal, Stephen M. Kaminsky. Stress-Induced Mouse Model of the Cardiac Manifestations of Friedreich's Ataxia Corrected by AAV-mediated Gene Therapy. Human Gene Therapy 2020; 31(15-16): 819 doi: 10.1089/hum.2019.363
|
| 37 |
Massimo Pandolfo. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. 2020; : 99 doi: 10.1016/B978-0-12-813866-3.00006-0
|
| 38 |
E.I. Demicheva, K. Shinwari, K.S. Ushenin, M.A. Bolkov. Additional Pathogenic Pathways in RBCK1 Deficiency. Mathematical Biology and Bioinformatics 2022; 17(2): 174 doi: 10.17537/2022.17.174
|
| 39 |
Ivelina P Kioutchoukova, Devon T Foster, Rajvi N Thakkar, Marco A Foreman, Brandon J Burgess, Rebecca M Toms, Eduardo E Molina Valero, Brandon Lucke-Wold. Neurologic orphan diseases: Emerging innovations and role for genetic treatments. World Journal of Experimental Medicine 2023; 13(4): 59-74 doi: 10.5493/wjem.v13.i4.59
Abstract(784) |
Core Tip(723) |
Full Article(HTML)(3109)
|
Full Article with Cover (PDF)-3034K(134)
|
Full Article (Word)-916K(40)
|
Audio-333K(3)
|
Peer-Review Report-234K(73)
|
Answering Reviewers-110K(77)
|
Full Article (PDF)-2841K(212)
|
Full Article (XML)-303K(72)
|
Times Cited (4)
|
Total Visits (7053)
|
Open
|
| 40 |
Antonella Bizzoca, Martina Caracciolo, Patrizia Corsi, Thea Magrone, Emilio Jirillo, Gianfranco Gennarini. Molecular and Cellular Substrates for the Friedreich Ataxia. Significance of Contactin Expression and of Antioxidant Administration. Molecules 2020; 25(18): 4085 doi: 10.3390/molecules25184085
|
| 41 |
Stefana Maria Moisa, Ingrith Crenguta Miron, Elena Tarca, Laura Trandafir, Vasile Valeriu Lupu, Ancuta Lupu, Tania Elena Rusu. Non-Cardiac Cause of Death in Selected Group Children with Cardiac Pathology: A Retrospective Single Institute Study. Children 2022; 9(3): 335 doi: 10.3390/children9030335
|
| 42 |
Joshua C. Chang, Molly R. Ryan, Marie C. Stark, Su Liu, Pravinkumar Purushothaman, Fria Bolan, Caitlin A. Johnson, Mark Champe, Hui Meng, Michael W. Lawlor, Sarah Halawani, Lucie V. Ngaba, David R. Lynch, Crystal Davis, Elena Gonzalo-Gil, Cathleen Lutz, Fabrizia Urbinati, Bala Medicherla, Carlos Fonck. AAV8 gene therapy reverses cardiac pathology and prevents early mortality in a mouse model of Friedreich’s ataxia. Molecular Therapy - Methods & Clinical Development 2024; 32(1): 101193 doi: 10.1016/j.omtm.2024.101193
|
| 43 |
Mert İlker Hayıroğlu, Koray Kalenderoğlu, Kadir Gürkan. Tachycardiomyopathy Treated With Ablation by Using 3D Mapping System in a Patient With Friedreich Ataxia. Pacing and Clinical Electrophysiology 2024; doi: 10.1111/pace.15125
|
| 44 |
Frances M. Smith, Daniel J. Kosman. Molecular Defects in Friedreich’s Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.569293
|
| 45 |
Serena Viventi, Stefano Frausin, Sara E. Howden, Shiang Y. Lim, Rocio K. Finol-Urdaneta, Jeffrey R. McArthur, Kwaku Dad Abu-Bonsrah, Wayne Ng, Jason Ivanusic, Lachlan Thompson, Mirella Dottori. In Vivo Survival and Differentiation of Friedreich Ataxia iPSC-Derived Sensory Neurons Transplanted in the Adult Dorsal Root Ganglia. Stem Cells Translational Medicine 2021; 10(8): 1157 doi: 10.1002/sctm.20-0334
|
| 46 |
Anya Hadji, Aurélie Louit, Vincent Roy, Mathieu Blais, François Berthod, François Gros-Louis, Nicolas Dupré. Trials for Cerebellar Ataxias. Contemporary Clinical Neuroscience 2023; : 141 doi: 10.1007/978-3-031-24345-5_5
|
| 47 |
Arianne Clare Agdamag, Phoo Pwint Nandar, W. H. Wilson Tang. Advanced Heart Failure Therapies in Neuromuscular Diseases. Current Treatment Options in Cardiovascular Medicine 2024; 26(8): 255 doi: 10.1007/s11936-024-01046-2
|
| 48 |
Francisco Figueroa, Lili Salinas, Phung N. Thai, Claire B. Montgomery, Nipavan Chiamvimonvat, Gino Cortopassi, Elena N. Dedkova. Poincaré plot analysis of electrocardiogram uncovers beneficial effects of omaveloxolone in a mouse model of Friedreich's ataxia. Heart Rhythm 2025; doi: 10.1016/j.hrthm.2024.12.041
|